Centaurus Financial’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.41M | Buy |
89,149
+11,655
| +15% | +$592K | 0.17% | 134 |
|
|
2026
Q1 | $4.13M | Sell |
77,494
-139
| -0.2% | -$8.16K | 0.2% | 114 |
|
|
2025
Q4 | $4.83M | Buy |
77,633
+1,339
| +2% | +$82.7K | 0.22% | 99 |
|
|
2025
Q3 | $4.58M | Sell |
76,294
-1,370
| -2% | -$83.8K | 0.22% | 104 |
|
|
2025
Q2 | $4.87M | Buy |
77,664
+1,215
| +2% | +$73K | 0.28% | 83 |
|
|
2025
Q1 | $4.6M | Buy |
76,449
+865
| +1% | +$53.7K | 0.28% | 80 |
|
|
2024
Q4 | $4.41M | Sell |
75,584
-3,564
| -5% | -$212K | 0.27% | 84 |
|
|
2024
Q3 | $4.69M | Buy |
79,148
+635
| +0.8% | +$36.3K | 0.3% | 74 |
|
|
2024
Q2 | $4.4M | Buy |
78,513
+3,293
| +4% | +$184K | 0.29% | 84 |
|
|
2024
Q1 | $4.41M | Sell |
75,220
-27,872
| -27% | -$1.57M | 0.31% | 76 |
|
|
2023
Q4 | $5.56M | Buy |
103,092
+27,958
| +37% | +$1.37M | 0.42% | 54 |
|
|
2023
Q3 | $3.64M | Sell |
75,134
-30,146
| -29% | -$1.6M | 0.32% | 76 |
|
|
2023
Q2 | $5.94M | Buy |
105,280
+19,803
| +23% | +$1.09M | 0.52% | 44 |
|
|
2023
Q1 | $4.61M | Sell |
85,477
-13,198
| -13% | -$703K | 0.37% | 64 |
|
|
2022
Q4 | $5.19M | Buy |
98,675
+20,949
| +27% | +$1.06M | 0.49% | 45 |
|
|
2022
Q3 | $3.67M | Buy |
77,726
+2,621
| +3% | +$136K | 0.36% | 62 |
|
|
2022
Q2 | $3.79M | Sell |
75,105
-13,406
| -15% | -$731K | 0.37% | 60 |
|
|
2022
Q1 | $5.4M | Sell |
88,511
-19,573
| -18% | -$1.17M | 0.43% | 47 |
|
|
2021
Q4 | $7.12M | Sell |
108,084
-37,994
| -26% | -$2.43M | 0.54% | 34 |
|
|
2021
Q3 | $9.17M | Buy |
146,078
+19,268
| +15% | +$1.23M | 0.77% | 19 |
|
|
2021
Q2 | $7.63M | Buy |
126,810
+14,382
| +13% | +$832K | 0.64% | 25 |
|
|
2021
Q1 | $6.19M | Buy |
112,428
+41,136
| +58% | +$2.28M | 0.61% | 29 |
|
|
2020
Q4 | $3.89M | Buy |
71,292
+4,104
| +6% | +$215K | 0.41% | 56 |
|
|
2020
Q3 | $3.35M | Buy |
67,188
+24,084
| +56% | +$1.17M | 0.46% | 54 |
|
|
2020
Q2 | $1.9M | Buy |
43,104
+2,262
| +6% | +$96.7K | 0.28% | 93 |
|
|
2020
Q1 | $1.53M | Sell |
40,842
-6,990
| -15% | -$294K | 0.31% | 90 |
|
|
2019
Q4 | $2.11M | Buy |
47,832
+1,626
| +4% | +$68.4K | 0.3% | 80 |
|
|
2019
Q3 | $1.9M | Sell |
46,206
-23,472
| -34% | -$961K | 0.3% | 91 |
|
|
2019
Q2 | $2.79M | Buy |
69,678
+59,754
| +602% | +$2.26M | 0.44% | 57 |
|
|
2019
Q1 | $383K | Buy |
+9,924
| New | +$360K | 0.07% | 290 |
|
|
2018
Q4 | – | Sell |
-18,000
| Closed | -$569K | – | 505 |
|
|
2018
Q3 | $569K | Buy |
18,000
+3,894
| +28% | +$138K | 0.1% | 225 |
|
|
2018
Q2 | $472K | Buy |
14,106
+9,156
| +185% | +$298K | 0.07% | 321 |
|
|
2018
Q1 | $153K | Sell |
4,950
-13,464
| -73% | -$415K | 0.04% | 367 |
|
|
2017
Q4 | $533K | Buy |
+18,414
| New | +$531K | 0.14% | 174 |
|
Other funds holding IHI
AAS
Centaurus Financial's IHI Position: Q2 2026 in Review
Centaurus Financial increased its iShares US Medical Devices ETF (IHI) stake by 15% in Q2 2026, buying an estimated $592K and bringing the position to 89,149 shares worth $4.41M. The position accounts for 0.17% of the portfolio, ranked #134.
Centaurus Financial first reported a position in IHI in Q4 2017 and has held it in 34 quarters since. The position peaked at $9.17M in Q3 2021. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Centaurus Financial held 89,149 shares of iShares US Medical Devices ETF worth $4.41M as of Q2 2026.
- Centaurus Financial bought 11,655 iShares US Medical Devices ETF shares in Q2 2026, an estimated $592K.
- iShares US Medical Devices ETF made up 0.17% of Centaurus Financial's portfolio in Q2 2026, its #134 holding.
- Centaurus Financial first reported a position in iShares US Medical Devices ETF in Q4 2017 and has held it in 34 quarters since.
- Centaurus Financial's iShares US Medical Devices ETF position peaked at $9.17M in Q3 2021.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.